ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

In Brief: Rhode Island, Los Angeles Approved For NCI Community Implementation Awards; Hawaii Close

July 8, 1977

Black Women More Likely To Have Aggressive, Less Treatable Breast Cancer

September 28, 2007